The Role of Telomeres and Telomerase in Cellular Aging and Disease: Mechanisms, Implications, and Therapeutic Interventions
Article Sidebar
Page Numbers:
95-104
Digital Object Identifier:
10.58578/ajbmbr.v2i2.5151
Viewed: 330 times
Downloaded: 288 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:Grace Christopher1, Lazarus Joseph Goje2
Copyright :Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
Telomeres, the protective caps at the ends of chromosomes, play a crucial role in maintaining genomic stability. This review explores the structure and function of telomeres, the mechanisms of telomere shortening, and the role of telomerase in counteracting this process. Telomere shortening is a natural consequence of cell division and is associated with cellular aging, senescence, and apoptosis. The review delves into the molecular biology of telomeres, highlighting the significance of the shelterin complex in protecting telomeres from degradation and fusion. It also discusses the genetic and epigenetic factors influencing telomere length, the impact of oxidative stress and inflammation on telomere attrition, and potential interventions to preserve telomere length. The review concludes with recommendations for lifestyle changes and therapeutic strategies to mitigate telomere shortening and promote healthy aging.
Downloads
Article Details
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Blackburn, E. H. (2001). Switching and signaling at the telomere. Cell 106 (6), 661–673.
Blackburn, E. H., Epel, E. S., and Lin, J. (2015a). Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Sci. (1979) 350 (6265), 1193–1198.
Cassidy, A., De Vivo, I., Liu, Y., Han, J., Prescott, J., Hunter, D. J., et al (2010). Associations between diet, lifestyle factors, and telomere length in women. The American journal of clinical nutrition, 91(5), 1273-1280.
Cawthon, R.M., Smith, K.R., and O’Brien E., (2003). Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 361:393–395.
Chang, X., Dorajoo, R., Sun, Y., Wang, L., Ong, C. N., Liu, J., et al. (2020). Effect of plasma polyunsaturated fatty acid levels on leukocyte telomere lengths in the Singaporean Chinese population. Nutr. J. 19 (1), 119.
D’Adda di Fagagna, F., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., et al (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198.
De Lange, T. (2005). The protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100–2110
De Lange, T. (2018). Shelterin-mediated telomere protection. Annu. Rev. Genet. 52 (1),223–247.
Deo, P., Dhillon, V.S., Lim, W. M., Jaunay, E.L., Donnellan., Peake., et al (2020). Advanced glycation end-products accelerate telomere attrition and increase proinflammatory mediators in human WIL2-NS cells. Mutagenesis 35 (3), 291–297.
El-Chemaly, S., Cheung., Kotliarov, Y., O’Brien, K.J., Gahl, W.A., Chen, J., et al. (2018). The immunome in two inherited forms of pulmonary fibrosis. Front. Immunol. 9:2018. doi: 10.3389/fimmu.2018
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., et al (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences, 101(49), 17312-17315.
Farzaneh-Far R., Cawthon RM., and Na B, (2008). Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol. 28:1379–1384.
Greider, C. W and Blackburn, E. H. (1985). Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 43 (2), 405–413.
Harley, C. B., Futcher, A. B., and Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345 (6274), 458–460.
Idrees, M., Kumar, V., Khan, A. M., Joo, M. D., Lee, K. W., Sohn, S. H., et al. (2023). Cycloastragenol activation of telomerase improves β-Klotho protein level and attenuates age-related malfunctioning in ovarian tissues. Mech. Ageing Dev. 209, 111756.
Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams A, et al. (2011). Telomerase reactivation reverse tissue degeneration in aged-telomerase deficient mice. Nature;469;102-1206
Johnson, F. B., Marciniak, R. A., McVey, M., Stewart, S. A., & Hahn, W. C. (2010). Imetelstat (GRN163L)—telomerase-based cancer therapy. Recent Results in Cancer Research, 184, 221-234.
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., et al. (2014). Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 5 (1), 4172.
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and de Lange, T. (1999). p53-and ATMdependent apoptosis induced by telomeres lacking TRF2. Sci. (1979) 283 (5406), 1321–1325.
LaRocca, T. J., Seals, D. R., & Pierce, G. L. (2010). Leukocyte telomere length is preserved with aging in endurance exercise-trained adults and related to maximal aerobic capacity. Mechanisms of ageing and development, 131(2), 165-167.
Levy MZ., Allsopp RC., Futcher AB., Greider CW., Harley CB., (1992). Telomere end-replication problem and cell aging. J Mol Biol.225:951-960.
Rodríguez-Rodero, S., Fernández-Morera, J. L., Menéndez-Torre, E., Calvanese, V., Fernández, A. F., Fraga, M. F. (2011). Aging Genetics and Aging. Aging Dis. 2(3): 186–195.
Salvador, L., Singaravelu, G., Harley, C. B., Flom, P., Suram, A., and Raffaele, J. M. (2016). A natural product telomerase activator lengthens telomeres in humans: a randomized, double blind, and placebo-controlled study. Rejuvenation Res. 19 (6), 478–484.
Singh, K., Saso, K., and Saso, L. (2019). Oxidative stress: role and response of short guanine tracts at genomic locations. Int. J. Mol. Sci. 20 (17), 4258. doi:10.3390/ ijms20174258
Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R. et al (2007) The POT1−TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506–510 12
Wu XM, Tang WR, Luo Y. [Alt – alternative lengthening of telomere]. Yi Chuan 2009;31(12):1185-91
Zhang, J., Rane, G., Dai, X., Shanmugam, M. K., Arfuso, F., Samy, R. P., et al. (2016). Ageing and the telomere connection: An intimate relationship with inflammation. Ageing Research Reviews, 25, 55-69.